Drug Trial Radar · NCT07619131
A Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Laroprovstat, Rosuvastatin and Placebo on LDL-C in LLT-naïve Patients.
Last checked: Nov 20, 2026Latest source record: Sep 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
600
Planned (sponsor's estimate)
Start
Aug 12, 2026
Primary completion
Jul 30, 2027
Study completion Jul 30, 2027
Sponsor
- Lead sponsor
- AstraZenecaAstraZeneca (AZN)
- Sponsor type
- Industry
- First posted
- Jun 1, 2026
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Factorial
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 130 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a study to evaluate the effect on LDL-C and the safety and tolerability of FDC laroprovstat/rosuvastatin in LLT-naïve patients. Laroprovstat is a small molecule that reduces the amount of LDL-C in the blood. Laroprovstat and FDC laroprovstat/rosuvastatin are being developed for the treatment of hypercholesterolaemia.
Conditions
- Hypercholesterolaemia
Interventions
LaroprovstatDrug
daily oral dose of the Laroprovstat
Rosuvastatin 1Drug
daily oral dose of the Rosuvastatin 1
Rosuvastatin 2Drug
daily oral dose of the Rosuvastatin 2
Laroprovstat/Rosuvastatin 1Drug
daily oral dose of the Laroprovstat/Rosuvastatin 1
Placebo to match rosuvastatinDrug
daily oral dose of the Placebo to match Rosuvastatin
Placebo to match Laroprovstat and Laroprovstat/Rosuvastatin 1Drug
daily oral dose of the Placebo to match Laroprovstat and Laroprovstat/Rosuvastatin 1
Laroprovstat/Rosuvastatin 2Drug
daily oral dose of the Laroprovstat/Rosuvastatin 2
Placebo to match Laroprovstat/Rosuvastatin 2Drug
daily oral dose of the Placebo to match Laroprovstat/Rosuvastatin 2
Primary outcomes
What the sponsor says the trial is designed to measure.
- Relative change in LDL-C at 8 weeksTime frame: 8 weeks
- Relative change in LDL-C at 8 weeksTime frame: 8 weeks
Locations
152 sites in 11 countries. Site status is shown where the registry gives one.
Research Site
Dothan, Alabama · Not yet recruiting
Research Site
Chandler, Arizona · Not yet recruiting
Research Site
Phoenix, Arizona · Not yet recruiting
Research Site
Huntington Beach, California · Not yet recruiting
Research Site
Loma Linda, California · Not yet recruiting
Research Site
Lomita, California · Not yet recruiting
Research Site
Long Beach, California · Not yet recruiting
Research Site
San Dimas, California · Not yet recruiting
Research Site
Arvada, Colorado · Not yet recruiting
Research Site
Colorado Springs, Colorado · Recruiting
Research Site
Waterbury, Connecticut · Not yet recruiting
Research Site
Clearwater, Florida · Not yet recruiting
Research Site
DeLand, Florida · Not yet recruiting
Research Site
Hollywood, Florida · Not yet recruiting
Research Site
Jacksonville, Florida · Not yet recruiting
Research Site
Lakeland, Florida · Recruiting
Research Site
Miami Lakes, Florida · Not yet recruiting
Research Site
Ocoee, Florida · Not yet recruiting
Research Site
Plantation, Florida · Not yet recruiting
Research Site
Port Orange, Florida · Not yet recruiting
Research Site
Tampa, Florida · Not yet recruiting
Research Site
Atlanta, Georgia · Not yet recruiting
Research Site
Conyers, Georgia · Recruiting
Research Site
Decatur, Georgia · Not yet recruiting
Research Site
Hinesville, Georgia · Recruiting
Research Site
Peachtree Corners, Georgia · Not yet recruiting
Research Site
Champaign, Illinois · Not yet recruiting
Research Site
Chicago, Illinois · Not yet recruiting
Research Site
Chicago, Illinois · Not yet recruiting
Research Site
Island Lake, Illinois · Not yet recruiting
Research Site
Melrose Park, Illinois · Not yet recruiting
Research Site
Palos Hills, Illinois · Not yet recruiting
Research Site
Evansville, Indiana · Not yet recruiting
Research Site
Waterloo, Iowa · Not yet recruiting
Research Site
Derby, Kansas · Not yet recruiting
Research Site
Lexington, Kentucky · Recruiting
Research Site
Louisville, Kentucky · Not yet recruiting
Research Site
Zachary, Louisiana · Not yet recruiting
Research Site
Annapolis, Maryland · Not yet recruiting
Research Site
Beltsville, Maryland · Not yet recruiting
Showing 40 of 152 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.